Stephens & Co. Reiterates Overweight on Privia Health Gr, Maintains $32 Price Target

Benzinga · 1d ago
Stephens & Co. analyst Jeff Garro reiterates Privia Health Gr (NASDAQ:PRVA) with a Overweight and maintains $32 price target.